JPRN-UMIN000013700
Recruiting
未知
Surveillance for esophageal cancer using NBI endoscopy - NBI surveillance
Osaka City University Graduate School of Medicine0 sites100 target enrollmentApril 12, 2014
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Superficial esophageal squamous cell carcinoma
- Sponsor
- Osaka City University Graduate School of Medicine
- Enrollment
- 100
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1\) esophageal and pharyngeal stricture (2\) previous surgical resection or chemotherapy, radiotherapy, or chemoradiotherapy for esophageal SCC (3\) patients with active malignant cancer or presence of serious complications (liver, kidney, heart, blood, or metabolic disorders) (4\) other reasons which made the subject ineligible to participate in this study, at the discretion of the chief investigator.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Improved screening of esophageal cancer by optical detection of field cancerization.1. Malignant cells in Barretts esophagus. 2. Field carcinogenesis.1001799010017991NL-OMON43548Academisch Medisch Centrum60
Active, not recruiting
Phase 1
Detection of early stages of esophageal cancer with fluorescence molecular endoscopy.Patients with Barretts esophagus and there is a suspicion for at least low grade dysplasia.Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2018-004745-17-NLniversity Medical Center Groningen60
Recruiting
Not Applicable
Investigation of the esophageal lesions using endocytoscopy systemesophageal lesionsJPRN-UMIN000007627Saitama Medical Center, Saitama Medical University80
Suspended
Not Applicable
Non-endoscopic EC Screening Program in Northern IranEsophageal CancerNCT02311712Tehran University of Medical Sciences12,000
Recruiting
Not Applicable
functional esophageal-and gastric-cancer screeningStomach, unspecifiedC15.9C16.9Oesophagus, unspecifiedDRKS00005037Institut für Kreislaufforschung und SportmedizinAbteilung molekulare und zelluläre Sportmedizin180